ATF3 and hepatocellular carcinoma: However, Kaplan–Meier plot and log-rank tests revealed that genetic mutations in ATF3 were not significantly associated with a lower OS (Fig. 4b, P = 0.665) or disease-free survival (DFS) (Fig. 4c, P = 0.479) in patients with HCC.